Stock CMOTEC B SCANDINAVIAN CHEMOTECH AB
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Scandinavian ChemoTech AB

Equities

CMOTEC B

SE0009242654

Market Closed - Nasdaq Stockholm
Other stock markets
 11:08:31 2024-06-04 EDT 		5-day change 1st Jan Change
1.78 SEK -5.82% Intraday chart for Scandinavian ChemoTech AB -11.44% -34.07%
05-27 ChemoTech's Animal Care Division Secures Important Order in Germany for a vetIQure TSE system CI
05-07 Scandinavian ChemoTech AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
  • With an enterprise value anticipated at 2.99 times the sales for the current fiscal year, the company turns out to be overvalued.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
SCANDINAVIAN CHEMOTECH AB Stock Scandinavian ChemoTech AB
-34.07% 3.25M -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+7.32% 217B
B
DANAHER CORPORATION Stock Danaher Corporation
+13.83% 194B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+20.48% 143B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+31.33% 111B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+3.08% 64.3B
A-
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+14.64% 52.94B
B+
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+2.72% 49.53B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-5.88% 38.31B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.25% 35.22B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
  1. Stock Market
  2. Equities
  3. CMOTEC B Stock
  4. Ratings Scandinavian ChemoTech AB